Testing a new stool test for early colon cancer detection
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 69 years old.
- You had a positive FIT or FOBT stool test and are set to have a colonoscopy.
- You have no symptoms and are at average risk for colorectal cancer (no personal history of adenomas, colorectal cancer, or inflammatory bowel disease, and no family history of colorectal cancer in a first-degree relative).
- You have not had any other cancer or chemotherapy/radiotherapy in the past 5 years.
- You have not had polyps removed in the past 5 years.
- You do not have familial adenomatous polyposis, Lynch syndrome, or inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new stool-based test for detecting colorectal cancer and advanced polyps. It aims to see how well it works compared to a colonoscopy. The results may lead to a simpler screening option.
This study checks stool samples to see how well stool tests can detect early colon cancer and precancerous growths called adenomas. If you qualify, you’ll collect stool samples for a lab test (FIT) and sometimes this helps sort who should get follow-up testing.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This trial offers free screening for colorectal cancer using a stool test for people aged 45-74. It is for those who haven't had certain colorectal tests recently and are generally healthy.
This trial tests a new blood test to screen for colorectal cancer in people at average risk. You would give a blood sample before your scheduled colonoscopy, and the results will be compared to the colonoscopy findings.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
Hear when a new Survey and Questionnaire trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.